Report Code: A13353 | Nov 2023 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Estrogen Receptor-positive Breast Cancer Pipeline Market
Request Now !Estrogen receptor positive (ER +) breast cancer is the most common type of breast cancer diagnosed. It refers to cancer cells that have estrogen-binding receptors on their surface. Breast cancer is said to have a positive estrogen receptor (ER +). Breast cancer is a syndrome that affects the breast tissues. Breast cells grow out of control, forming bumps that can be felt or seen on x-rays. Selective estrogen receptor modulators such as tamoxifen is prescribed to reduce risk of endometrial cancer. Moreover, surgery such as mastectomy, medications such asletrozole, radiation, and chemotherapy are used in treatment of estrogen receptor positive breast cancer.
COVID-19 Impact Analysis            Â
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the estrogen receptor positive breast cancer pipeline market.
Top Impacting Factors
Market Trends
New Product Launches to Flourish the Market
In 2020, Eisai Co. Ltd. announced launch of series of products, LENVIMA, HALAVEN, and H3B-6545. This therapeutic products help in treatment of ER positive breast cancer and HER2 negative breast cancer.
In 2019, Mylan announced launch of its generic version of Faslodex injection in U.S. This product is used in treatment of hormone receptor positive such as estrogen receptor positive breast cancer.
Key Benefits of the Report
Questions Answered in the Estrogen Receptor Positive Breast Cancer Pipeline Market Report
Estrogen Receptor-Positive Breast Cancer Pipeline Market Report Highlights
Aspects | Details |
---|---|
By Phase |
|
By Route of Administration |
|
By Target |
|
By Region |
|
By End User |
|
Key Market Players | AstraZeneca, GlaxoSmithKline plc, Genentech, Inc., Mylan Pharmaceuticals Inc., Pfizer Inc., Novartis AG, Teva Pharmaceuticals USA, Inc., Alvogen., Apotex Corp., Breckenridge Pharmaceutical, Inc. |
Start reading.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers